Abstract:Background: Systemic lupus erythematosus (SLE) is the prototype of autoimmune disease and is characterized by the production of a variety of autoantibodies. and lupus nephritis continues to be a principal cause of morbidity and mortality.The focus is to finding biomarkers that can monitor renal activity and predict prognosis for early diagnosis and treatment. Complement C1q is the starter molecule of the classical pathway of complement activation and plays an important role in the clearance of immune complexes and apoptotic cell debris. Hereditary homozygous deficiency of C1q has been described to be the strongest risk factor for developing SLE.There are some cross-sectional studies on anti-C1q in which the antibody was found to have a significant association with renal involvement but the association of anti-C1q antibodies (antiC1q) with lupus nephritis (LN) still a matter of debate. Objectives: We assessed the association between lupus nephritis disease activity and anti-C1q antibodies Methods: We retrospectively analyzed the medical records of 88 patients with lupus nephritis, aged 35.7±10.8 years on the average, with SLE of average duration 12 (3, 57) years.In all examines the levels of anti-dsDNA and anti-C1q antibodies were measured using the ELISA, C3, C4, 24-hour urinary protein performed in parallel were reviewed. The Clinical manifestations of SLE was also collected.Lupus nephritis disease activity was measured by The SLICC Renal Activity Score of 2004,All biopsied tissues were scored based on the to ISN/RPS2003 lupus nephritis pathological typing standards,Acute Index,Chronic Index Score were used to evaluated the activities of lupus, All the analyses were performed by SPSS 20.0 software. Results: Patients with active lupus nephritis had a higher levels of anti-C1q antibodies than inactive lupus nephritis (68.9(34.1, 140.1)vs. 11.6(5.5, 44.1); p<0.001)(Figure 1). Anti-C1q antibody levels were positively correlated with levels of 24-hour urinary protein(r=0.605; P=0.000),AI score(r=0.337; P=0.001),and negatively correlated with serum C3(r=-0.573; P=0.000) and C4 (r=-0.509; P=0.000).(Figure2). Figure 2 A: Anti-C1q antibody levels were positively correlated with AI score Figure 2 B: Anti-C1q antibody levels were positively correlated with levels of 24-hour urinary protein Figure2-C:Anti-C1q antibody levels were positively correlated with C3 Figure2-D:Anti-C1q antibody levels were positively correlated with C4 Conclusion: Anti-C1q antibodies are more closely correlated with renal disease activity. References [1] Clarke AE, Panopalis P, Petri M, Manzi S, Isenberg DA, Gordon C, et al. SLE patients with renal damage incur higher health care costs[J]. Rheumatology (Oxford, England). 2008;47(3):329-33. [2] Walport MJ. Complement. First of two parts[J]. N Engl J Med. 2001;344(14):1058. [3] Walport MJ. Complement. Second of two parts[J]. N Engl J Med. 2001;344(15):1140. [4] Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus[J]. Autoimmunity. 2007;40(8):560-6. [5] Akhter E,., Burlingame RW, Seaman AL, Magder L,., Petri M,. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers[J]. Lupus. 2011;20(12):1267-74. Disclosure of Interests: None declared

Anti‐C1q Antibodies in Lupus Nephritis Children with Glomerular Microthrombosis

Antiphospholipid Antibody Profiles in Lupus Nephritis with Glomerular Microthrombosis: a Prospective Study of 124 Cases.

[Correlation of Anti-C1q Antibodies with Active Systemic Lupus Erythematosus and Lupus Nephritis in Children].

Relationship between Blood Lipid Profiles and Risk of Lupus Nephritis in Children

Detection of Anti-C1q Antibodies and Anti-C1q Globular Head Domain Antibodies in Sera from Chinese Patients with Lupus Nephritis.

Characteristics and Renal Survival of Patients with Lupus Nephritis with Glomerular Immunoglobulin G4 Deposition: a Single-Centre Retrospective Analysis.

Antiphospholipid Antibodies in Patients with Membranous Nephropathy.

Anti-C1q Antibodies and IgG Subclass Distribution in Sera from Chinese Patients with Lupus Nephritis.

Antiphospholipid Antibody and Childhood Lupus Nephritis

Clinical course of lupus membranous glomerulonephritis in children

C3dg and MAC Complement Depositions in the Renal Histopathology of Patients with Lupus Nephropathy.

[C1q or IgA deposition in glomeruli of children with primary membranous nephropathy]

Glomerular C1q Deposition and Serum Anti-C1q Antibodies in Anti-Glomerular Basement Membrane Disease.

SAT0673 ANTI-C1Q ANTIBODIES HAVE HIGHER CORRELATION WITH LUPUS NEPHRITIS DISEASE ACTIVITY

Serum Levels and Renal Deposition of C1q Complement Component and Its Antibodies Reflect Disease Activity of Lupus Nephritis

Relationship Between Anti-C1q Antibody and Renal Pathology of Lupus Nephritis

Circulating anti-C3b IgG in lupus nephritis: A large cohort study

Clinical and pathological analysis of 41 children with lupus nephritis

Coexistence of Anti-Glomerular Basement Membrane Antibodies and Anti-Neutrophil Cytoplasmic Antibodies in a Child with Human Leukocyte Antigen Susceptibility and Detailed Antibody Description: A Case Report.

Renal C4d is a potential biomarker of disease activity and severity in pediatric lupus nephritis patients

Clinical Significance of the Serum Anti - C1q Antibody in Evaluating the Activity of Systemic Lupus Erythematosus and the Pathological Type of Lupus Renal